Factors influencing the prenatal detection of structural congenital heart diseases

S F Wong1, F Y Chan, R B Cincotta

  • 1Department of Maternal Fetal Medicine, Mater Mothers' Hospital, South Brisbane, Queensland, Australia. shellwong@hotmail.com

Insights

Prenatal ultrasound detected 40.4% of congenital heart diseases (CHDs). Detection rates improved with complex lesions, experienced sonographers, and additional anomalies, highlighting areas for enhanced prenatal screening.

Area of Science:

  • Perinatology
  • Fetal Medicine
  • Cardiology

Background:

  • Congenital heart diseases (CHDs) are a significant cause of infant mortality and morbidity.
  • Prenatal detection of structural CHDs is crucial for improving perinatal outcomes.
  • Factors influencing the accuracy of prenatal CHD detection require further investigation.

Purpose of the Study:

  • To evaluate the key determinants affecting the prenatal detection rate of structural congenital heart diseases (CHDs).
  • To identify specific lesion types and patient characteristics associated with higher detection rates.
  • To assess the impact of sonographer experience and co-existing anomalies on diagnostic accuracy.

Main Methods:

  • Retrospective analysis of fetal and infant medical records with diagnosed CHDs.
  • Inclusion of pregnancies with prenatal ultrasound morphological surveys.
  • Assessment of lesion complexity, sonographer experience, co-existing anomalies, and maternal BMI as influencing factors.

Main Results:

  • The overall prenatal detection rate for structural CHDs was 40.4%.
  • Detection rates were significantly higher for complex lesions (54%), lesions with abnormal four-chamber views (62.9%), and concomitant septal defects (66.7%).
  • Higher detection rates were observed in tertiary institutions and when chromosomal or structural anomalies were present; maternal BMI was not a significant factor.

Conclusions:

  • While major CHDs can be detected with a high rate in screening settings, significant improvements are needed.
  • Enhanced scanning skills, particularly in four-chamber view and great-artery analysis, are essential in both tertiary and local centers.
  • Operator experience and lesion complexity are critical independent predictors of successful prenatal CHD detection.
Abstract

Related Concept Videos

Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Development of the Heart01:27

Development of the Heart

The development of the human heart, a crucial organ, commences from the mesoderm on the 18th or 19th day after fertilization. This process initiates in the cardiogenic area, a group of mesodermal cells at the embryo's head end, which evolves into elongated strands known as cardiogenic cords. These cords undergo a transformation to form hollow-centered endocardial tubes.
As the embryo undergoes lateral folding, these paired tubes approach each other, merging into a single primitive heart tube by...
Fetal Circulation01:14

Fetal Circulation

Fetal circulation is a unique system that facilitates the exchange of gases, nutrients, and waste products between the developing fetus and the mother. This intricate process takes place through a special organ called the placenta.
Two umbilical arteries transport blood from the fetus to the placenta. At the placenta, the blood absorbs oxygen and nutrients while simultaneously eliminating waste products. This oxygen-enriched and nutrient-rich blood then returns to the fetus through one...
Imaging Studies for Cardiovascular System III: X-Ray01:20

Imaging Studies for Cardiovascular System III: X-Ray

The most common cardiovascular diagnostic test is an X-ray. It produces images of the heart, blood vessels, and adjacent structures.
Definition and Purpose
An X-ray, or radiograph, is a non-invasive method that uses ionizing radiation to take images of internal structures. It is mainly used in cardiac imaging to examine the heart, lungs, and major blood vessels, aiming to identify abnormalities in the heart's size, shape, and position, such as heart failure, congenital defects, and vascular...
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...